Sheryl F. Kelsey

Q: What Schools Are Affiliated With Sheryl F. Kelsey

Sheryl F. Kelsey is affiliated with the following schools: Boston University, Emory University, Carnegie Mellon University, Mount Holyoke College, University of Pittsburgh

Sheryl F. Kelsey's AcademicInfluence.com Rankings

Sheryl F. Kelsey

Medical

#2234

World Rank

#2642

Historical Rank

Epidemiology

#391

World Rank

#410

Historical Rank

medical Degrees

Sheryl F. Kelsey

Mathematics

#6228

World Rank

#8666

Historical Rank

Statistics

#568

World Rank

#648

Historical Rank

mathematics Degrees

Download Badge

Medical
Mathematics

Why Is Sheryl F. Kelsey Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Sheryl F. Kelsey is an American biostatistician and epidemiologist who became the first woman to earn a doctorate in statistics from Carnegie Mellon University. She made significant contributions to how heart disease is treated by studying the outcomes of coronary angioplasty.

(See a Problem?)

Sheryl F. Kelsey's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

A randomized trial of therapies for type 2 diabetes and coronary artery disease. (2009) (1778)
Restenosis after percutaneous transluminal coronary angioplasty (PTCA): a report from the PTCA Registry of the National Heart, Lung, and Blood Institute. (1984) (1138)
Treatment of traumatic brain injury with moderate hypothermia. (1997) (1048)
Percutaneous transluminal coronary angioplasty in 1985-1986 and 1977-1981. The National Heart, Lung, and Blood Institute Registry. (1988) (844)
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part II: gender differences in presentation, diagnosis, and outcome with regard to gender-based pathophysiology of atherosclerosis and macrovascular and microvascular coronary disease. (2006) (807)
Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials (2009) (730)
Effects of therapy with cholestyramine on progression of coronary arteriosclerosis: results of the NHLBI Type II Coronary Intervention Study. (1984) (719)
Insights from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study: Part I: gender differences in traditional and novel risk factors, symptom evaluation, and gender-optimized diagnostic strategies. (2006) (706)
Menopause and risk factors for coronary heart disease. (1990) (673)
Spectrum and susceptibilities of microbiologic isolates in the Endophthalmitis Vitrectomy Study. (1996) (642)
The prognostic value of exercise testing in patients with cystic fibrosis. (1992) (590)
Percutaneous Transluminal Coronary Angioplasty: Report of Complications from the National Heart, Lung, and Blood Institute PTCA Registry (1983) (578)
Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. (2009) (510)
Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study. (2001) (508)
Coronary angioplasty in diabetic patients. The National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1996) (493)
Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation. (2008) (461)
Assessment of neurological prognosis in comatose survivors of cardiac arrest (1994) (447)
Abnormal myocardial phosphorus-31 nuclear magnetic resonance spectroscopy in women with chest pain but normal coronary angiograms. (2000) (426)
Menopause and Risk Factors for Coronary Heart Disease (1989) (425)
Acute coronary events associated with percutaneous transluminal coronary angioplasty. (1984) (425)
Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) Study (2004) (422)
Prognosis in Women With Myocardial Ischemia in the Absence of Obstructive Coronary Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2004) (421)
Percutaneous transluminal coronary angioplasty: report from the Registry of the National Heart, Lung, and Blood Institute. (1982) (412)
Serum Amyloid A as a Predictor of Coronary Artery Disease and Cardiovascular Outcome in Women: The National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2004) (410)
The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease: results of NHLBI Type II Coronary Intervention Study. (1984) (395)
Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. (2002) (378)
The Women's Ischemia Syndrome Evaluation (WISE) study: protocol design, methodology and feasibility report. (1999) (343)
Comparison of complications during percutaneous transluminal coronary angioplasty from 1977 to 1981 and from 1985 to 1986: the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1988) (336)
Percutaneous Coronary Intervention in the Current Era Compared With 1985–1986: The National Heart, Lung, and Blood Institute Registries (2000) (335)
Outcome Analysis of Acoustic Neuroma Management: A Comparison of Microsurgery and Stereotactic Radiosurgery: 215 (1995) (333)
Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease. (2013) (303)
Better outcome for women compared with men undergoing coronary revascularization: a report from the bypass angioplasty revascularization investigation (BARI) (1998) (301)
Results of percutaneous transluminal coronary angioplasty in women. 1985-1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry. (1993) (299)
The Economic Burden of Angina in Women With Suspected Ischemic Heart Disease: Results From the National Institutes of Health–National Heart, Lung, and Blood Institute–Sponsored Women’s Ischemia Syndrome Evaluation (2006) (298)
Sex differences in early and long-term results of coronary angioplasty in the NHLBI PTCA Registry. (1985) (286)
Detailed angiographic analysis of women with suspected ischemic chest pain (pilot phase data from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation [WISE] Study Angiographic Core Laboratory). (2001) (279)
Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study. (2003) (275)
Educational attainment and behavioral and biologic risk factors for coronary heart disease in middle-aged women. (1989) (274)
Cause-Specific Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes (2010) (273)
INTERMEDIATE-DENSITY LIPOPROTEINS AND PROGRESSION OF CORONARY ARTERY DISEASE IN HYPERCHOLESTEROLAEMIC MEN (1987) (272)
Depression, inflammation, and incident cardiovascular disease in women with suspected coronary ischemia: the National Heart, Lung, and Blood Institute-sponsored WISE study. (2007) (266)
Persistent chest pain predicts cardiovascular events in women without obstructive coronary artery disease: results from the NIH-NHLBI-sponsored Women's Ischaemia Syndrome Evaluation (WISE) study. (2005) (262)
Relationship of physical fitness vs body mass index with coronary artery disease and cardiovascular events in women. (2004) (255)
One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry. (1989) (233)
Influences of natural menopause on psychological characteristics and symptoms of middle-aged healthy women. (1990) (220)
Long term outcomes after moderate to severe traumatic brain injury (2004) (209)
Physical activity and functional status in community-dwelling older women: a 14-year prospective study. (2003) (206)
A comparison of bare-metal and drug-eluting stents for off-label indications. (2008) (205)
Improved outcomes for women undergoing contemporary percutaneous coronary intervention: a report from the National Heart, Lung, and Blood Institute Dynamic registry. (2002) (205)
Predictors of Microalbuminuria in Individuals with IDDM: Pittsburgh Epidemiology of Diabetes Complications Study (1993) (193)
Relationship of physical fitness vs body mass Index with coronary artery disease and cardiovascular events in women (2004) (181)
Association Between Poor Sleep, Fatigue, and Safety Outcomes in Emergency Medical Services Providers (2012) (180)
Long-term efficacy of percutaneous transluminal coronary angioplasty (PTCA): report from the National Heart, Lung, and Blood Institute PTCA Registry. (1984) (179)
Emergency coronary bypass surgery after coronary angioplasty: the National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry experience. (1984) (176)
Safety of coronary reactivity testing in women with no obstructive coronary artery disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. (2012) (172)
Non–High-Density Lipoprotein Cholesterol Levels Predict Five-Year Outcome in the Bypass Angioplasty Revascularization Investigation (BARI) (2002) (167)
In women with symptoms of cardiac ischemia, nonobstructive coronary arteries, and microvascular dysfunction, angiotensin-converting enzyme inhibition is associated with improved microvascular function: A double-blind randomized study from the National Heart, Lung and Blood Institute Women's Ischemia (2011) (166)
Habitual physical activity in children and adolescents with cystic fibrosis. (2001) (160)
The impact of estrogen and progesterone on asthma. (2003) (154)
The value of estimated functional capacity in estimating outcome: results from the NHBLI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (145)
Adverse outcomes among women presenting with signs and symptoms of ischemia and no obstructive coronary artery disease: findings from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) angiographic core laboratory. (2013) (142)
Evaluation of microbiological diagnostic techniques in postoperative endophthalmitis in the Endophthalmitis Vitrectomy Study. (1997) (140)
Measurement Variability in Duplex Scan Assessment of Carotid Atherosclerosis (1992) (138)
The Endophthalmitis Vitrectomy Study. Relationship between clinical presentation and microbiologic spectrum. (1997) (137)
Social Networks Are Associated With Lower Mortality Rates Among Women With Suspected Coronary Disease: The National Heart, Lung, and Blood Institute-Sponsored Women’s Ischemia Syndrome Evaluation Study (2004) (137)
Impact of age on procedural and 1-year outcome in percutaneous transluminal coronary angioplasty: a report from the NHLBI Dynamic Registry. (2003) (134)
Predictors of Carotid Stenosis in Older Adults With and Without Isolated Systolic Hypertension (1993) (132)
Measuring Diabetic Neuropathy: Assessment and Comparison of Clinical Examination and Quantitative Sensory Testing (1989) (131)
Impact of Abnormal Coronary Reactivity on Long-Term Clinical Outcomes in Women. (2019) (130)
All-Cause Mortality Trends in a Large Population-Based Cohort With Long-Standing Childhood-Onset Type 1 Diabetes (2010) (124)
Angina 1 year after percutaneous coronary intervention: a report from the NHLBI Dynamic Registry. (2002) (123)
Strength vs aerobic training in children with cystic fibrosis: a randomized controlled trial. (2004) (117)
Association Between Maternal Infections and Preeclampsia: A Systematic Review of Epidemiologic Studies (2008) (116)
Two-year clinical outcomes after enhanced external counterpulsation (EECP) therapy in patients with refractory angina pectoris and left ventricular dysfunction (report from The International EECP Patient Registry). (2006) (115)
The international EECP patient registry (IEPR): Design, methods, baseline characteristics, and acute results (2001) (113)
Clinical presentation of Mycoplasma genitalium Infection versus Neisseria gonorrhoeae infection among women with pelvic inflammatory disease. (2009) (113)
Failure of cefoxitin and doxycycline to eradicate endometrial Mycoplasma genitalium and the consequence for clinical cure of pelvic inflammatory disease (2008) (110)
Effect of investigator experience on percutaneous transluminal coronary angioplasty. (1984) (103)
Retinal detachment in the endophthalmitis vitrectomy study. (2000) (103)
Efficacy of repeat percutaneous transluminal coronary angioplasty for coronary restenosis. (1984) (102)
Weight cycling and high-density lipoprotein cholesterol in women: evidence of an adverse effect: a report from the NHLBI-sponsored WISE study. Women's Ischemia Syndrome Evaluation Study Group. (2000) (101)
Hypotheses, design, and methods for the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial. (2006) (101)
Clinical infections in the noninstitutionalized geriatric age group: methods utilized and incidence of infections. The Pittsburgh Good Health Study. (1995) (100)
Choice of urine sample predictive of microalbuminuria in patients with insulin-dependent diabetes mellitus. (1989) (97)
Prognostic value of global MR myocardial perfusion imaging in women with suspected myocardial ischemia and no obstructive coronary disease: results from the NHLBI-sponsored WISE (Women's Ischemia Syndrome Evaluation) study. (2010) (95)
The association of diabetes specialist care with health care practices and glycemic control in patients with type 1 diabetes: a cross-sectional analysis from the Pittsburgh epidemiology of diabetes complications study. (2000) (95)
Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. The Liposorber Study Group. (1992) (95)
Improved resuscitation outcome in emergency medical systems with increased usage of sodium bicarbonate during cardiopulmonary resuscitation (2005) (94)
Symptoms, myocardial ischaemia and quality of life in women: results from the NHLBI-sponsored WISE Study. (2003) (94)
Assessment of Cerebral Blood Flow and CO2 Reactivity after Controlled Cortical Impact by Perfusion Magnetic Resonance Imaging using Arterial Spin-Labeling in Rats (1997) (91)
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system (1998) (90)
Preterm Delivery and Later Maternal Cardiovascular Disease Risk (2007) (89)
In-hospital mortality rate in the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1984) (89)
Neurologic recovery after cardiac arrest: Effect of duration of ischemia (1985) (88)
A randomized clinical trial of the clinical effects of enhanced heart failure monitoring using a computer-based telephonic monitoring system in older minorities and women. (2007) (87)
Degree of revascularization in patients with multivessel coronary disease: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1988) (85)
Hypertension, menopause, and coronary artery disease risk in the Women's Ischemia Syndrome Evaluation (WISE) Study. (2006) (85)
Depression symptom severity and reported treatment history in the prediction of cardiac risk in women with suspected myocardial ischemia: The NHLBI-sponsored WISE study. (2006) (82)
Social Networks and Incident Stroke Among Women With Suspected Myocardial Ischemia (2008) (81)
Twenty-Year Evolution of Percutaneous Coronary Intervention and Its Impact on Clinical Outcomes: A Report From the National Heart, Lung, and Blood Institute–Sponsored, Multicenter 1985–1986 PTCA and 1997–2006 Dynamic Registries (2008) (81)
Characteristics of noncontraceptive hormone users. (1988) (81)
Natural History of Infant Reflux Esophagitis: Symptoms and Morphometric Histology During One Year Without Pharmacotherapy (2006) (81)
Two-year outcomes after enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry [IEPR]). (2004) (79)
Modeling and Risk Prediction in the Current Era of Interventional Cardiology: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry (2003) (78)
Percutaneous transluminal coronary angioplasty (PTCA) in the elderly patient: experience in the National Heart, Lung, and Blood Institute PTCA Registry. (1984) (77)
Large brachial artery diameter is associated with angiographic coronary artery disease in women. (2002) (76)
Adiposity and Mortality in Type 1 Diabetes (2009) (76)
Results of percutaneous transluminal coronary angioplasty in patients ≥65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry)☆ (1990) (74)
Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial (2015) (73)
Characteristics of women with hysterectomy. (1989) (73)
Determination of menopausal status in women: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2004) (69)
Randomized Trial Comparing Locoregional Resection of Primary Tumor with No Surgery in Stage IV Breast Cancer at the Presentation (Protocol MF07‐01): A Study of Turkish Federation of the National Societies for Breast Diseases (2009) (68)
Rosiglitazone and Outcomes for Patients With Diabetes Mellitus and Coronary Artery Disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2013) (67)
Electrocardiographic predictors of cardiovascular outcome in women: the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) study. (2005) (66)
Psychosocial Variables Are Associated With Atherosclerosis Risk Factors Among Women With Chest Pain: The WISE Study (2001) (66)
Design of the PID Evaluation and Clinical Health (PEACH) Study. (1998) (64)
Differences in Medical Therapy Goals for Children With Severe Traumatic Brain Injury—An International Study (2013) (64)
Additional procedures after the initial vitrectomy or tap-biopsy in the Endophthalmitis Vitrectomy Study. (1998) (64)
Diabetes and postoperative endophthalmitis in the endophthalmitis vitrectomy study. (2001) (64)
Obesity, obesity-related behaviors and coronary heart disease risk factors in black and white premenopausal women. (1989) (63)
Cardiovascular Disease and 10-Year Mortality in Postmenopausal Women with Clinical Features of Polycystic Ovary Syndrome. (2016) (62)
Baseline characteristics of patients in the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1984) (60)
Multifaceted Therapy After Global Brain Ischemia in Monkeys (1984) (60)
Cardiopulmonary bypass after cardiac arrest and prolonged closed-chest CPR in dogs. (1987) (60)
Influence of health care providers on the development of diabetes complications: long-term follow-up from the Pittsburgh Epidemiology of Diabetes Complications Study. (2002) (59)
Accuracy and reliability of maternal recall of infant birth weight among older women. (2006) (59)
Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 5: gender-related risk factors for ischemic heart disease. (2004) (58)
Ten-Year Mortality in the WISE Study (Women’s Ischemia Syndrome Evaluation) (2017) (57)
Premenopausal determinants of menopausal estrogen use. (1991) (57)
Cardiovascular and Mortality Risk of Apparent Resistant Hypertension in Women With Suspected Myocardial Ischemia: A Report From the NHLBI‐Sponsored WISE Study (2014) (57)
Determinants of successful percutaneous transluminal coronary angioplasty: report from the National Heart, Lung, and Blood Institute Registry. (1984) (56)
Depression Is Associated With Cardiac Symptoms, Mortality Risk, and Hospitalization Among Women With Suspected Coronary Disease: The NHLBI-Sponsored WISE Study (2006) (56)
Cardiopulmonary bypass after prolonged cardiac arrest in dogs. (1987) (56)
Importance of socioeconomic status as a predictor of cardiovascular outcome and costs of care in women with suspected myocardial ischemia. Results from the National Institutes of Health, National Heart, Lung and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2008) (55)
Subclinical atherosclerosis and estimated glucose disposal rate as predictors of mortality in type 1 diabetes. (2002) (55)
Physical activity and functional capacity measurement in women: a report from the NHLBI-sponsored WISE study. (2000) (55)
Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. (2001) (55)
Microbiologic yields and complication rates of vitreous needle aspiration versus mechanized vitreous biopsy in the Endophthalmitis Vitrectomy Study. (1999) (54)
SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. (2017) (53)
Abstract S2-03: Early follow up of a randomized trial evaluating resection of the primary breast tumor in women presenting with de novo stage IV breast cancer; Turkish study (protocol MF07-01) (2013) (52)
Impact of drug-eluting stents among insulin-treated diabetic patients: a report from the National Heart, Lung, and Blood Institute Dynamic Registry. (2008) (52)
Menopausal symptoms and cardiovascular disease mortality in the Women's Ischemia Syndrome Evaluation (WISE) (2017) (51)
Migraines, angiographic coronary artery disease and cardiovascular outcomes in women. (2006) (51)
Effect of age in the Bypass Angioplasty Revascularization Investigation (BARI) randomized trial. (1999) (51)
Baseline Characteristics of Patients with Diabetes and Coronary Artery Disease Enrolled in the BARI 2D Trial (2008) (50)
Brain Enzyme Levels in CSF after Cardiac Arrest and Resuscitation in Dogs: Markers of Damage and Predictors of Outcome (1988) (50)
Percutaneous transluminal coronary angioplasty (PTCA) in patients with relative contraindications: results of the National Heart, Lung, and Blood Institute PTCA Registry. (1984) (49)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993–1994 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry) (1997) (49)
Enhanced external counterpulsation as treatment for chronic angina in patients with left ventricular dysfunction: a report from the International EECP Patient Registry (IEPR). (2002) (49)
The presenting ECG pattern in survivors of cardiac arrest and its relation to the subsequent long‐term survival (1989) (48)
Hormonal and barrier contraception and risk of upper genital tract disease in the PID Evaluation and Clinical Health (PEACH) study. (2001) (48)
Hostility Scores Are Associated With Increased Risk of Cardiovascular Events in Women Undergoing Coronary Angiography: A Report from the NHLBI-Sponsored WISE Study (2005) (47)
Cost of medical services in older patients with heart failure: those receiving enhanced monitoring using a computer-based telephonic monitoring system compared with those in usual care: the Heart Failure Home Care trial. (2010) (46)
Outcome of percutaneous transluminal coronary angioplasty in subsets of unstable angina pectoris. A report of the 1985-1986 National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1994) (46)
Reliability of assessing change with sequential coronary angiography. (1982) (45)
Association between infant birth weight and maternal cardiovascular risk factors in the health, aging, and body composition study. (2007) (45)
Baseline characteristics of patients with diabetes and coronary artery disease enrolled in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. (2008) (43)
National Heart, Lung, and Blood Institute type II Coronary Intervention Study: design, methods, and baseline characteristics. (1982) (43)
Effect of gender on prognosis following percutaneous coronary intervention for stable angina pectoris and acute coronary syndromes. (2006) (43)
History of anxiety disorders is associated with a decreased likelihood of angiographic coronary artery disease in women with chest pain: the WISE study. (2001) (42)
Cause of death analysis in the NHLBI PTCA Registry: results and considerations for evaluating long-term survival after coronary interventions. (1997) (42)
Temporal Trends in Patient-Reported Angina at 1 Year After Percutaneous Coronary Revascularization in the Stent Era: A Report From the National Heart, Lung, and Blood Institute–Sponsored 1997–2006 Dynamic Registry (2009) (41)
Benefit of long-term dual anti-platelet therapy in patients treated with drug-eluting stents: from the NHLBI dynamic registry. (2013) (41)
Socioeconomic Status Variables Predict Cardiovascular Disease Risk Factors and Prospective Mortality Risk among Women with Chest Pain (2003) (41)
Ethnic differences in the presentation, treatment strategy, and outcomes of percutaneous coronary intervention (a report from the National Heart, Lung, and Blood Institute Dynamic Registry). (2003) (41)
The demographic, sexual health and behavioural correlates of Mycoplasma genitalium infection among women with clinically suspected pelvic inflammatory disease (2009) (40)
Benefit and Safety of Enhanced External Counterpulsation in Treating Coronary Artery Disease Patients with a History of Congestive Heart Failure (2001) (40)
Morbidity, mortality, and antihypertensive treatment effects by extent of atherosclerosis in older adults with isolated systolic hypertension. (1995) (40)
Return to work after coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1984) (39)
Inflammatory biomarkers as predictors of heart failure in women without obstructive coronary artery disease: A report from the NHLBI-sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2017) (39)
A randomized controlled trial of low-dose hormone therapy on myocardial ischemia in postmenopausal women with no obstructive coronary artery disease: results from the National Institutes of Health/National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2010) (38)
Total estrogen time and obstructive coronary disease in women: insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2009) (36)
Primer: practical approach to the selection of patients for and application of EECP (2006) (36)
Simpson's paradox and clinical trials: what you find is not necessarily what you prove. (1992) (35)
Has improvement in PTCA intervention affected long-term prognosis? The NHLBI PTCA Registry experience. (1995) (34)
Does higher diastolic augmentation predict clinical benefit from enhanced external counterpulsation?: Data from the international EECP patient registry (IEPR) (2001) (34)
C-reactive protein is associated with aortic stiffness in a cohort of African American and white women transitioning through menopause (2011) (34)
TREATMENT OF ENDOPHTHALMITIS AFTER CATARACT EXTRACTION (1994) (34)
Peroxisome Proliferator-Activated Receptor Pathway Gene Polymorphism Associated With Extent of Coronary Artery Disease in Patients With Type 2 Diabetes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (2011) (34)
Comparison of patients undergoing enhanced external counterpulsation and percutaneous coronary intervention for stable angina pectoris. (2002) (33)
Two‐year outcomes in patients with mild refractory angina treated with enhanced external counterpulsation (2006) (33)
Timing of hormone therapy, type of menopause, and coronary disease in women: data from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (2011) (33)
Hormone replacement therapy and lipoprotein changes during early menopause. (1990) (32)
Lipid-lowering medication use and aggression scores in women: a report from the NHLBI-sponsored WISE study. (2008) (32)
The effect of age on clinical outcomes and health status BARI 2D (Bypass Angioplasty Revascularization Investigation in Type 2 Diabetes). (2011) (32)
Relation of the pattern of diastolic augmentation during a course of enhanced external counterpulsation (EECP) to clinical benefit (from the International EECP Patient Registry [IEPR]). (2002) (32)
Comparison of bare-metal and drug-eluting stents in patients with chronic kidney disease (from the NHLBI Dynamic Registry). (2011) (31)
Diabetes mellitus, hypothalamic hypoestrogenemia, and coronary artery disease in premenopausal women (from the National Heart, Lung, and Blood Institute sponsored WISE study). (2008) (31)
Reproductive history of women dying of sudden cardiac death: a case-control study. (1989) (30)
Obesity distribution and reproductive hormone levels in women: a report from the NHLBI-sponsored WISE Study. (2006) (30)
Phytoestrogens and lipoproteins in women. (2006) (30)
Clinical use of sodium bicarbonate during cardiopulmonary resuscitation--is it used sensibly? (2002) (29)
Incidence and predictors of 30-day hospital readmission rate following percutaneous coronary intervention (from the National Heart, Lung, and Blood Institute Dynamic Registry). (2012) (29)
Percutaneous transluminal coronary angioplasty in African-American patients (the National Heart, Lung, and Blood Institute 1985-1986 Percutaneous Transluminal Coronary Angioplasty Registry). (1994) (28)
Impact of external counterpulsation treatment on emergency department visits and hospitalizations in refractory angina patients with left ventricular dysfunction. (2007) (28)
Incidence and predictors of target vessel revascularization following percutaneous transluminal coronary angioplasty: a report from the National Heart, Lung, and Blood Institute Percutaneous Transluminal Coronary Angioplasty Registry. (1999) (28)
Multimarker Approach Predicts Adverse Cardiovascular Events in Women Evaluated for Suspected Ischemia: Results from the National Heart, Lung, and Blood Institute–Sponsored Women's Ischemia Syndrome Evaluation (2009) (27)
Progression of coronary atherosclerosis in patients with probable familial hypercholesterolemia. Quantitative arteriographic assessment of patients in NHLBI type II study. (1989) (27)
Predictors of Benefit in Angina Patients One Year after Completing Enhanced External Counterpulsation: Initial Responders to Treatment versus Nonresponders (2005) (26)
Cholesterol-lowering medication, cholesterol level, and reproductive hormones in women: the Women's Ischemia Syndrome Evaluation (WISE). (2002) (25)
Characteristics after cataract extraction or secondary lens implantation among patients screened for the Endophthalmitis Vitrectomy Study. (2000) (24)
NHLBI percutaneous transluminal coronary angioplasty (PTCA) registry: Four years experience (1982) (24)
Documentation of decline in morbidity in women undergoing coronary angioplasty (a report from the 1993-94 NHLBI Percutaneous Transluminal Coronary Angioplasty Registry). National Heart, Lung, and Blood Institute. (1997) (23)
An investigation of the hospital charges related to the treatment of endophthalmitis in the Endophthalmitis Vitrectomy Study. (1997) (23)
Ankle-brachial index and cardiovascular outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes trial. (2012) (23)
Results of percutaneous transluminal coronary angioplasty in patients greater than or equal to 65 years of age (from the 1985 to 1986 National Heart, Lung, and Blood Institute's Coronary Angioplasty Registry). (1990) (22)
Long-term effects of low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption system. Liposorber Study Group. (1998) (22)
Diabetes and postcataract extraction endophthalmitis. (2002) (22)
Short and long term outcome of percutaneous transluminal coronary angioplasty in unstable versus stable angina pectoris: a report of the 1985-1986 NHLBI PTCA Registry. (1991) (22)
Completeness of revascularization for multivessel coronary artery disease and its effect on one-year outcome: a report from the NHLBI Dynamic Registry. (2007) (21)
Long-term follow-up of coronary angioplasty: the 1977-1981 National Heart, Lung, and Blood Institute registry. (1989) (21)
The Epidemiology of Acute Poisonings in Women of Reproductive Age and During Pregnancy, California, 2000–2004 (2011) (21)
Angina patients with diastolic versus systolic heart failure demonstrate comparable immediate and one-year benefit from enhanced external counterpulsation. (2003) (21)
TIMI Frame Count and Adverse Events in Women with No Obstructive Coronary Disease: A Pilot Study from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2014) (21)
Analysis of baseline factors associated with reduction in chest pain in patients with angina pectoris treated by enhanced external counterpulsation. (2003) (21)
Sudden Cardiac Death in Women With Suspected Ischemic Heart Disease, Preserved Ejection Fraction, and No Obstructive Coronary Artery Disease: A Report From the Women's Ischemia Syndrome Evaluation Study (2017) (21)
Myocardial Scar Is Prevalent and Associated With Subclinical Myocardial Dysfunction in Women With Suspected Ischemia But No Obstructive Coronary Artery Disease: From the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction Study. (2018) (20)
Long-term analysis of conventional coronary balloon angioplasty and an initial "stent-like" result. The NHLBI PTCA Registry. (1998) (20)
Augmentation laser for proliferative diabetic retinopathy that fails to respond to initial panretinal photocoagulation. (1992) (20)
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease (2005) (19)
Frequency and efficacy of repeat enhanced external counterpulsation for stable angina pectoris (from the International EECP Patient Registry). (2005) (18)
Predictors of electromechanical dissociation during cardiac arrest. (1988) (18)
Effect of coronary angiography on use of lipid-lowering agents in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. For the WISE Investigators. (2000) (18)
Prevalence of Coronary Endothelial and Microvascular Dysfunction in Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease Is Confirmed by a New Cohort: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation–Coronary Vascular Dysfunction (WISE-CVD) (2019) (17)
Impact of body mass index on outcomes of enhanced external counterpulsation therapy. (2006) (17)
Effects of an Intravenous Lipid Challenge and Free Fatty Acid Elevation on In Vivo Insulin Sensitivity in African American Versus Caucasian Adolescents (2009) (17)
Percutaneous Coronary Intervention in the Current Era Compared With 1985 – 1986 (2000) (17)
Hormone replacement, race, and psychological health in women: a report from the NHLBI-Sponsored WISE Study. (2004) (17)
Evolution of Percutaneous Coronary Intervention in Patients with Diabetes (2010) (16)
Sex Differences in Secondary Attack Rate of IDDM to Siblings of Probands Through Older Ages: Pittsburgh Etiology of IDDM Study (1992) (16)
Double-edged relationship between adiposity and coronary artery calcification in type 1 diabetes (2007) (16)
Exercise intensity self‐regulation using the OMNI scale in children with cystic fibrosis (2013) (16)
Electrocardiogram abnormalities predict angiographic coronary artery disease in women with chest pain: Results from the nhlbi wise study (2002) (16)
Cross-sectional analysis of Toll-like receptor variants and bacterial vaginosis in African–American women with pelvic inflammatory disease (2014) (15)
Left Ventricular Energy Model Predicts Adverse Events in Women With Suspected Myocardial Ischemia: Results From The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study. (2013) (15)
Effectiveness of enhanced external counterpulsation in patients with left main disease and angina (2004) (15)
Distal Support and Community Living Among Individuals Diagnosed with Schizophrenia and Schizoaffective Disorder (2007) (15)
Paclitaxel-Eluting Versus Sirolimus-Eluting Stents in Diabetes Mellitus: A Report From the National Heart, Lung, and Blood Institute Dynamic Registry (2010) (15)
Inflammation, endothelial cell activation, and coronary microvascular dysfunction in women with chest pain and no obstructive coronary artery disease. (2005) (14)
Impact evaluation in resuscitation research: discussion of clinical trials. (1988) (14)
Genetic loci associated with nonobstructive coronary artery disease in Caucasian women. (2016) (14)
Birth outcomes following self-inflicted poisoning during pregnancy, California, 2000 to 2004. (2011) (13)
The efficacy and safety of enhanced external counterpulsation in patients with peripheral arterial disease (2010) (13)
Cardiac syndrome X: Relation to microvascular angina and other conditions (2007) (13)
Effectiveness of Repeat Enhanced External Counterpulsation for Refractory Angina in Patients Failing to Complete an Initial Course of Therapy (2006) (12)
Secondary prevention and lipid lowering: results and implications. (1985) (11)
Regional adiposity and risk for coronary artery disease in type 1 diabetes: does having greater amounts of gluteal-femoral adiposity lower the risk? (2010) (11)
Relationships between Cerebrovascular Events, APOE Polymorphism and Alzheimer’s Disease in a Community Sample (2000) (11)
Comparison of immediate and one-year outcome after coronary angioplasty of narrowing < 3 mm with those > or =3 mm ( the National Heart, Lung, and Blood Institute Dynamic Registry). (2001) (11)
Trends in major entry site complications from percutaneous coronary intervention (from the Dynamic Registry). (2014) (11)
Analysis of the bypass angioplasty revascularization investigation trial using a multistate model of clinical outcomes. (2015) (10)
Trends in coronary revascularization 1989 to 1997: the Bypass Angioplasty Revascularization Investigation (BARI) survey of procedures. (1999) (10)
Comparison of long term clinical outcomes, event free survival rates of patients undergoing enhanced external counterpulsation for coronary artery disease in the United States and Turkey. (2012) (10)
Comparison of long-term safety and efficacy outcomes after drug-eluting and bare-metal stent use across racial groups: Insights from NHLBI Dynamic Registry. (2015) (10)
Enhanced external counterpulsation is a safe and effective treatment for angina in patients with severe left ventricular dysfunction (1999) (10)
An international collaborative clinical study mechanism for resuscitation research. (1982) (10)
Angina Hospitalization Rates in Women With Signs and Symptoms of Ischemia But no Obstructive Coronary Artery Disease: A Report from the WISE (Women's Ischemia Syndrome Evaluation) Study (2020) (9)
Clinical Risk Assessment in Women (2004) (8)
Residual high-grade angina after enhanced external counterpulsation therapy. (2007) (8)
EARLY-ONSET MENOPAUSAL VASOMOTOR SYMPTOMS ARE ASSOCIATED WITH ENDOTHELIAL DYSFUNCTION: THE NATIONAL HEART LUNG AND BLOOD INSTITUTE-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2015) (8)
801-1 In women with symptoms of ischemic heart disease, global and regional myocardial perfusion status by magnetic resonance imaging better assigns risk: Results from the National Heart, Lung, and Blood Institute-sponsored Women's Ischemia Syndrome Evaluation (WISE) (2004) (7)
Neurologic Outcome Of Survivors Of Cardiac Arrest (1982) (7)
Patients with diabetes did better with coronary bypass graft surgery than with percutaneous transluminal coronary angioplasty: was this BARI finding real? (1999) (7)
Phytoestrogens and coronary microvascular function in women with suspected myocardial ischemia: a report from the Women's Ischemia Syndrome Evaluation (WISE) Study. (2007) (7)
Body mass index and health status in the Bypass Angioplasty Revascularization Investigation 2 Diabetes Trial (BARI 2D). (2011) (7)
Free fatty acids are associated with pulse pressure in women, but not men, with type 1 diabetes mellitus. (2009) (7)
RANDOMIZED CLINICAL STUDY OF THIOPENTAL (TH) LOADING AFTER CARDIAC ARREST. II: DEMOGRAPHIC DATA (1981) (7)
Clinical trials and cerebral resuscitation research. (1984) (7)
Passive tobacco exposure may impair symptomatic improvement in patients with chronic angina undergoing enhanced external counterpulsation (2008) (6)
Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent (2010) (6)
Initial and Continued Adherence With Bladder Cancer Screening in an Occupationally Exposed Cohort (2011) (6)
Is the relationship between depression and inflammatory markers modulated by coronary artery disease in women? The NHLBI-Sponsored women's ischemia syndrome evaluation (WISE) study (2006) (6)
1172-76 Healthcare costs for cardiovascular disease in women with and without obstructive coronary disease: Results from the National Institutes of Health-National Heart, Lung, and Blood Institutes-Sponsored Women's Ischemia Syndrome evaluation (WISE) (2004) (5)
Coronary angiography results have minimal impact on use of lipid-lowering agents in women: pilot phase data from WISE (1998) (5)
Eight year, long term outcome after PTCA: Factors associated with adverse events. The NHLBI PTCA registry (1996) (5)
CLINICAL SIGNS EARLY AFTER CPR PREDICT NEUROLOGIC OUTCOME (1999) (5)
Not typical angina and mortality in women with obstructive coronary artery disease: Results from the Women’s Ischemic Syndrome Evaluation study (WISE) (2020) (5)
Determinants of a successful percutaneous transluminal coronary angioplasty (NHLBI-PTCA registry) (1982) (5)
Weight cycling and cardiovascular outcome in women with suspected ischemia: A report from the NHLBI-sponsored WISE Study (2018) (5)
Stimulating an immune response? Oral sex is associated with less endometritis (2012) (5)
Collaborative randomized clinical study of cardiopulmonary-cerebral resuscitation. (1981) (5)
ASSOCIATION OF ABNORMAL ELECTROCARDIOGRAPHY RESPONSE ON STRESS ECHOCARDIOGRAM WITH MAJOR ADVERSE CARDIOVASCULAR EVENTS IN WOMEN: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2021) (5)
LONG-TERM FOLLOW-UP OF CARDIAC ARREST SURVIVORS (1982) (4)
Do the ethnic differences in presentation and treatment strategy influence outcomes of contemporary percutaneous coronary intervention? A report from the national heart, lung, and blood institute dynamic registry (2003) (4)
Predictors of adverse in-hospital events following percutaneous coronary revascularization in the current era: a report from the NHLBI dynamic registry (2002) (4)
Abnormal 31P NMR stress test is predictive of myocardial events: a report from the NIH-NHLBI sponsored Women's Ischemia Syndrome Evaluation(WISE) (2002) (4)
Improved diagnosis and prognosis using Decisions Informed by Combining Entities (DICE): results from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE). (2013) (4)
65 Treatment comparisons controlling for multiple testing (1997) (4)
Gender-Related Risk Factors for Ischemic Heart Disease (2004) (4)
Application of overnight urine collections and food records for monitoring the sodium and potassium intakes of groups and individuals. (1994) (4)
LATE GADOLINIUM ENHANCEMENT AND ADVERSE CARDIAC EVENTS AT 1 YEAR FOLLOW-UP IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY DISEASE: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (3)
Use of bio-informatics assessment schema (BIAS) to improve diagnosis and prognosis of myocardial perfusion data: results from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE). (2016) (3)
Aortic flow conditions predict ejection efficiency in the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE). (2017) (3)
Risk monitoring of randomized trials in emergency medicine: experience of the Brain Resuscitation Clinical Trial II. (1991) (3)
Body weight and physical fitness in women with ischaemic heart disease: does physical fitness contribute to our understanding of the obesity paradox in women? (2022) (3)
Coronary Artery Disease Liberal versus restrictive transfusion thresholds for patients with symptomatic coronary artery disease (2013) (2)
Response to letter regarding article, "rosiglitazone and outcomes for patients with diabetes mellitus and coronary artery disease in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial". (2014) (2)
Is enhanced external counterpulsation effective for angina relief in diabetic patients who are not candidates for transcatheter intervention (2003) (2)
Strategies for Statistical Analysis of Angiographic Data: Individual Lesions Versus Individual Patients (1990) (2)
Comparison of abbreviated versus full course of enhanced external counterpulsation in heart failure patients with one-year follow-up (2004) (2)
Electrocardiographic Predictors of Cardiovascular Outcome in Women (2016) (2)
DIFFERENTIAL EFFECTS OF COLD PRESSOR AND ACETYLCHOLINE DURING ENDOTHELIAL FUNCTION ASSESSMENT IN WOMEN WITH NO OBSTRUCTIVE CORONARY ARTERY DISEASE: THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2012) (2)
Syndrome Evaluation (WISE) Study National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Electrocardiographic Predictors of Cardiovascular Outcome in Women: The (2006) (2)
Abstract 2533: Paclitaxel-Eluting versus Sirolimus-Eluting Stents in Diabetes Mellitus (2008) (2)
BARI 2D: A Reanalysis Focusing on Cardiovascular Events. (2019) (2)
PREVALENCE OF MYOCARDIAL SCAR IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA BUT NO OBSTRUCTIVE CORONARY ARTERY DISEASE: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (2)
The impact of body weight on outcome after percutaneous coronary intervention — The obesity paradox revisited: A report from the National, Heart, Lung, and Blood Institute Dynamic Registry (2003) (2)
Factors, Symptom Evaluation, and Gender-Optimized Diagnostic Strategies (WISE) Study: Part I: Gender Differences in Traditional and Novel Risk Insights From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (2007) (2)
Measuring Physical Activity in Children with Cystic Fibrosis: Comparison of Four Methods (1993) (2)
P0789 CIMETIDINE, CISAPRIDE, BOTH, OR NEITHER FOR INFANTILE ESOPHAGITIS: SYMPTOMATIC RESPONSE TO 4M RANDOMIZED, DOUBLE BLIND, PLACEBO-CONTROLLED THERAPY IN 100 BABIES. (2004) (2)
EARLY PREDICTORS OF POOR NEUROLOGIC OUTCOME IN COMATOSE CARDIAC ARREST SURVIVORS (1986) (2)
P67 Data form entry using internet tools: The matrix system (1997) (1)
Abstract 20443: Sex-Specific Coronary Vascular Function Thresholds and Prognosis: A Report From the Women’s Ischemia Syndrome Evaluation (WISE) (2016) (1)
Endophthalmitis Vitrectomy Study-Reply (1996) (1)
COMPARATIVE EFFECTIVENESS OF RADIAL AND FEMORAL APPROACHES TO PERCUTANEOUS CORONARY INTERVENTION ON LONG-TERM OUTCOMES: A REPORT FROM THE NHLBI DYNAMIC REGISTRY (2010) (1)
Is enhanced external counterpulsation the preferred treatment for chronic stable angina in select patients 75 years and older (2003) (1)
The impact of diastolic augmentation ratio on treatment outcomes in patients with left ventricular dysfunction treated with enhanced external counterpulsation for angina management (2004) (1)
ANGINA AND ANTI-ANGINAL THERAPY IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE (2013) (1)
P92 Angiographic eligibility assessment in the bypass angioplasty revascularization investigation (1995) (1)
Abstract 3235: Twenty Years of Percutaneous Coronary Intervention - The Evolution and the Impact. A Report from the National Heart, Lung and Blood Institute-Sponsored PTCA (1985 86) and Dynamic (1997 2004) Registries (2006) (1)
Abstract P86: Cost-Effectiveness of Enhanced External Counterpulsation in Reducing Hospital Costs in Refractory Angina Patients (2011) (1)
176 Comparison of clinical outcomes, event free survival rates in patients with severe left ventricular dysfunction undergoing enhanced external counterpulsation and percutaneous coronary intervention (2004) (1)
Impact of Drug-Eluting Stents Among Insulin-Treated Diabetic Patients A Report from the NHLBI Dynamic Registry (2009) (1)
Hormone replacement therapy and lipoprotein changes during early menopause (1991) (1)
Sex Hormone and Atherosclerotic Risk Factor Profiles Are Not Determinants of Coronary Microvascular Reserve in Women With Chest Pain: Pilot Phase Results From WISE (1998) (1)
COULD RETINAL IMAGING PROVIDE A SIMPLE INEXPENSIVE NONINVASIVE INDEX FOR CORONARY MICROVASCULAR FUNCTION IN WOMEN WITH CHEST PAIN AND NONOBSTRUCTIVE CORONARY ARTERY DISEASE? AN ANCILLARY PILOT STUDY FROM THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE-ARIC) (2011) (1)
Long-Term Adverse Outcomes in Black Women With Ischemia and No Obstructive Coronary Artery Disease: A Study of the WISE (Women's Ischemia Syndrome Evaluation) Cohort. (2023) (1)
Abstract 804: Sudden Cardiac Death and Severity of Obstructive Coronary Artery Disease: A Report From the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2009) (1)
Abstract 2186: PPAR-Pathway Gene Polymorphisms Associated With Extent of Coronary Artery Disease in Patients With Type 2 Diabetes in the BARI 2D Trial (2009) (1)
Risk factors for heart failure in women with ischemia and no obstructive coronary artery disease (2021) (1)
Abstract 19568: African-American Ethnicity, Risk Variables, Coronary Artery Disease, and Long-Term Prognosis in Women: The National Heart, Lung, and Blood Institute Sponsored Women's Ischemia Syndrome Evaluation Study (2017) (1)
Decisions Informed by Computing Entities (DICE) to improve prognostic value of myocardial perfusion imaging: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2011) (1)
Coronary Intervention Study (2005) (1)
Abstract 2142: Off-Label Use of Drug-Eluting Stents: Safety and Efficacy Compared to Bare Metal Stents. A Report From the NHLBI Dynamic Registry. (2007) (1)
Enhanced External Counterpulsation Improves Functional Capacity in Patients with Left Ventricular Dysfunction as Assessed by the Duke Activity Status Index - A Questionnaire Correlated with Peak Oxygen Uptake (2003) (1)
CONSTRICTION OF THE BRACHIAL ARTERY DURING BRACHIAL ARTERY REACTIVITY TESTING PREDICTS MAJOR ADVERSE CLINICAL OUTCOMES IN WOMEN WITH SUSPECTED MYOCARDIAL ISCHEMIA: THE NHLBI-SPONSORED WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) STUDY (2010) (1)
INFLAMMATORY BIOMARKER IL-6 PREDICTS HEART FAILURE IN WOMEN WITH SIGNS AND SYMPTOMS OF ISCHEMIA AND NO OBSTRUCTIVE CORONARY ARTERY DISEASE: FINDINGS FROM THE NHLBI-SPONSORED WOMEN’S ISCHEMIC SYNDROME EVALUATION (WISE) STUDY (2016) (1)
Enhanced external counterpulsation for the relief of angina in patients with diabetes: A one-year clinical outcome study (2003) (1)
Abstract 19546: Differential Event Prediction Using Coronary Vascular Testing Results From the National Heart, Lung and Blood Institute Women’s Ischemia Syndrome Evaluation Study (2016) (1)
Abstract 14414: Treated Hypertension and Risk For Cardiovascular Events in Women: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2011) (1)
Abstract 10364: Noninvasive Detection of Microvascular Coronary Dysfunction Using Cardiac Magnetic Resonance Imaging: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2011) (1)
474 Impact of enhanced external counterpulsation (EECP) on symptoms, health status and medication use in patients with both angina and heart failure (2005) (1)
ANGINA AND MYOCARDIAL PERFUSION IMPROVE IN WOMEN WITH CORONARY MICROVASCULAR DYSFUNCTION AT 1 YEAR FOLLOW-UP: A REPORT FROM THE WOMEN’S ISCHEMIA SYNDROME EVALUATION (2015) (1)
Associated Medical Conditions in 63 Patients with MAC Hypertension Myocardial infarct Diabetes mellitus ' Mitral prolapse (2005) (0)
Abstract 3649: Menstrual Cycling and Mechanisms of Cardiovascular Disease Events in Post-Menopausal Women: Results from the NIH-NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
Can enhanced external counterpulsation provide a supportive approach to refractory angina patients with left ventricular dysfunction in the compulsory absence of recommended optimal treatment strategies (2003) (0)
Abstract 2450: A Randomized Controlled Trial of Low Dose Hormone Therapy on Myocardial Ischemia in Postmenopausal Women with No Obstructive Coronary Artery Disease:Results from the NHLBI-sponsored WISE (2007) (0)
A38 Proportional hazards model for assessing visual acuity data (1996) (0)
Abnormal myocardial phosphorus metabolism in the NIH-NHLBI sponsored Women's Ischemia Syndrome Evaluation (WISE): final phase I results (2002) (0)
Author's response to reviews Title: Association of an INSIG2 obesity allele with cardiovascular phenotypes is gender and age dependent Authors: (2010) (0)
Bio-informatics assessment schema (BIAS) to improve myocardial perfusion image diagnostic and prognostic value: the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study (2014) (0)
HRT modulates brachial artery diameter and flow-mediated dilation: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study (2002) (0)
Abstract 11580: Brachial Pulse Pressure Predicts Adverse Outcomes Including Heart Failure Hospitalizations in Women With Preserved Ejection Fraction and No Obstructive Coronary Artery Disease: A Report from the Women’s Ischemia Syndrome Evaluation (2014) (0)
A89 A dynamic approach to recruiting patients in a registry of coronary interventions (1996) (0)
THE ENDOPHTHALMITIS VITRECTOMY STUDY. AUTHORS' REPLIES (1996) (0)
Effectiveness of cardioprotective medication in women with suspected ischemic heart disease syndrome: the NHLBI-sponsored women's ischemia synrome evaluation (WISE) study (2011) (0)
891-3 Enhanced external counterpulsation improves functional capacity and quality of life in women with chronic angina (2004) (0)
Abstract 15668: All-Cause and Cardiovascular Mortality in Women Undergoing Coronary Angiography: New Data with Extended Follow-up of the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) (2011) (0)
Does expanded artificial intelligence improve the prognostic value of myocardial perfusion imaging? A report from the NHLBI-sponsored women's ischemia syndrome evaluation (WISE) (2013) (0)
Are cerebral benefits of an experimental calcium entry blocker negated by cardiovascular complications (1992) (0)
methodology and feasibility report The Women's Ischemia Syndrome Evaluation (WISE) Study: protocol design, (2007) (0)
AbstractEvaluation of benefit when intercurrent mortality is high (1981) (0)
72 ENHANCED EXTERNAL COUNTERPULSATION AS A SYSTEMIC TREATMENT OF DIABETICS WITH ANGINA AND HEART FAILURE (2005) (0)
ASSESSING PCI OUTCOMES AT 30 DAYS: ARE WE MOVING TOO FAST? A REPORT FROM THE NHLBI DYNAMIC REGISTRY (2010) (0)
DIABETES AND POSTOPERATIVE ENDOPHTHALMITIS VITRECTOMY STUDY (2002) (0)
Contents Vol. 19, 2000 (2000) (0)
Abstract 8974: Standard and off-Label Use of Drug-Eluting Stents and Patient-Reported Angina Three Years After Percutaneous Coronary Intervention - A Report From the NHLBI-sponsored Dynamic Registry (2010) (0)
Abstract 15436: Left Ventricular Ejection Fraction and MACE in Women With Signs and Symptoms of Ischemia: Data From the WISE (Women's Ischemia Syndrome Evaluation) (2020) (0)
Determinants of Brachial Artery Endothelial Function in Women: Pilot Phase Results From the WISE Clinical Centers (1998) (0)
A randomized clinical trial of brain resuscitation following cardiac arrest (1984) (0)
Does Completion of Enhanced External Counterpulsation Treatment Course Improve Outcomes in Heart Failure Patients (2008) (0)
Abstract 17055: A New Cohort Confirms the High Prevalence and Severity of Endothelial and Microvascular Dysfunction Among Women with Symptoms of Ischemia and No Obstructive Coronary Artery Disease: the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) (2011) (0)
IN WOMEN WITH SYMPTOMS OF CARDIAC ISCHEMIA, NONOBSTRUCTIVE CORONARY ARTERIES AND MICROVASCULAR DYSFUNCTION, ACE INHIBITION IS ASSOCIATED WITH IMPROVED MICROVASCULAR FUNCTION: A DOUBLE-BLIND RANDOMIZED ANCILLARY STUDY FROM THE NHLBI WOMEN’S ISCHEMIA SYNDROME EVALUATION (WISE) (2010) (0)
Determination of menopausal status in women The NHLBI-sponsored WISE study (1999) (0)
Abstract 2842: CMR-Determined Regional Myocardial Perfusion Uptake Rate Predicts Events in Women Without Obstructive Coronary Artery Disease: The NHLBI-Sponsored Women's Ischemia Syndrome Evaluation (WISE) Study (2006) (0)
Abstract 1991: Adverse Cardiovascular Outcomes in Women with No Obstructive Coronary Artery Disease: A Report From The NHLBI-sponsored WISE Study And The St James WTH Project (2006) (0)
CORONARY ARTERY DISEASE The influence of changes in lipid values induced by cholestyramine and diet on progression of coronary artery disease : results of the NHLBI pe II Coronary Intervention Study (2005) (0)
Abstract 14597: High Left Ventricular Ejection Fraction and All-cause Mortality in Women With Ischemia: Data From the WISE (Women's Ischemia Syndrome Evaluation) (2020) (0)
PREDICTION OF BRAIN DAMAGE IN COMATOSE PATIENTS AFTER CARDIAC ARREST (CA), USING CYTOSOLIC BRAIN ENZYME PEAK LEVELS IN CEREBROSPINAL FLUID (CSF) (1988) (0)
1077-74 Marked underutilization and geographic variation in secondary prevention pharmacologic therapy in patients with chronic angina undergoing treatment with enhanced external counterpulsation (2004) (0)
A27 Teaching the next generation of clinical trialists (1996) (0)
Abstract 10434: Non-Typical Angina and Mortality in Women With Obstructive Coronary Artery Disease: Results From the Women's Ischemia Syndrome Evaluation Study (WISE) (2015) (0)
Phytosetrogens have a potentially adverse effect on coronary vasodilator (endothelial independent) function in women with suspected ischemia: a report from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) study (2002) (0)
91204952 Premenopausal determinants of menopausal estrogen use (1991) (0)
Role of physical fitness in the obesity paradox. Long-term major adverse cardiovascular events in the Women's Ischemia Syndrome Evaluation (WISE) (2020) (0)
Effects of cholestyramine treatment on progression of coronary atherosclerosis: The NHLBI type II coronary intervention study (1984) (0)
Recording Neurological Symptoms And Signs In Alzheimer's Disease (1987) (0)
Comparative Effectiveness Review ( Addendum ) Number 9 Addendum Addendum to : Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Grafting for Coronary Artery Disease (2010) (0)
Contents Vol. 103, 2005 (2005) (0)
375-S: Association Between Infant Birth Weight and Maternal Cardiovascular Risk Factors: The Health, Aging and Body Composition Study (2005) (0)
PROGNOSTIC RISK FACTORS FOR HEART FAILURE HOSPITALIZATION IN WOMEN WITHOUT OBSTRUCTIVE CORONARY DISEASE: AN ANCILLARY STUDY FROM THE WOMEN'S ISCHEMIA SYNDROME EVALUATION (WISE) (2017) (0)
Abstract 2809: Insulin-Treated Diabetic Patients Have Attenuated Benefit of Drug-Eluting Stents After Percutaneous Coronary Intervention: A Report from the NHLBI Dynamic Registry (2006) (0)
DIET, ANGIOGRAPHIC CORONARY DISEASE, AND CARDIOVASCULAR OUTCOMES IN WOMEN (2022) (0)
BRIEF REPORT Phytoestrogens and Lipoproteins in Women (2006) (0)
90359829 Hormone replacement therapy and lipoprotein changes during early menopause (1991) (0)
Ankle-Brachial Index and Cardiovascular Outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) Trial (2012) (0)
Depression and cardiovascular events in women: Do inflammatory markers explain this relationship? The NHLBI-sponsored women's ischemia syndrome evaluation (WISE) study (2006) (0)
OP-064 LONG TERM CLINICAL OUTCOMES AND MAJOR ADVERSE CARDIAC EVENT RATES OF ENHANCED EXTERNAL COUNTERPULSATION THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE (2010) (0)
Enhanced External Counterpulsation in the Treatment of Angina Patients with Heart Failure and Diabetes (2006) (0)
Subject Index Vol. 103, 2005 (2005) (0)
Outcome 14 to 18 years after percutaneous transluminal coronary angioplasty. (2000) (0)
Long-term analysis of balloon angioplasty and an initial “stent-like” result: the 1985–86 NHLBI PTCA registry (1998) (0)
Using estimated functional capacity to optimize stress testing for diagnosis and prognosis of cardiovascular disease in women: The NHLBI-sponsored WISE study (2003) (0)
Appendix 2 Hypothetical Example Illustrating the Probability of In-Hospital Mortality in Patients Without Any Identified Risk Factors Based on the NY State and ACC Models (2003) (0)
Free Fatty Acids are Associated with Pulse Pressure in Women, but not Men, with Type 1 Diabetes (2009) (0)
Abstract 3771: Type of Menopause, Hormone Therapy and Coronary Artery Disease in Women: New Insights from the NHLBI-sponsored Women's Ischemia Syndrome Evaluation (WISE) (2007) (0)
Complications with Percutaneous Transluminal Coronary Angioplasty in 314 Patients Complication Prolonged angina Myocardial infarction Coronary occlusion Coronary spasm Dissection / intimal tear Hypotension (2005) (0)
Response to Dr Sandar et al. (2013) (0)
Percutaneous Transluminal Coronary Angioplasty After Myocardial Infarction (1988) (0)
The Altar of High Technology and the Excimer Laser (2016) (0)
Abstract 13544: Myocardial Perfusion Reserve by Cardiac Magnetic Resonance Imaging is Related to Angina Stability in Women with Signs and Symptoms of Ischemia and No Obstructive Coronary Artery Disease: Results from the NHLBI-Sponsored Women's Ischemia Syndrome Evaluation Coronary Vascular Dysfuncti (2012) (0)
918-20 Performance of Coronary Angioplasty in Patients with Multivessel Coronary Artery Disease: Observations from the Bypass Angioplasty Revascularization Investigation (BARI) (1995) (0)
LONG-TERM OUTCOMES OF DRUG-ELUTING STENTS FOR OFF-LABEL INDICATIONS: A REPORT FROM THE NHLBI DYNAMIC REGISTRY (2010) (0)
TCT-363 Safety and long-term outcomes after percutaneous coronary interventions in patients with liver disease: report from the National Heart, Lung, and Blood Institute Dynamic Registry (2012) (0)
Persistent chest pain at 1-year predicts long-term angina hospitalization in women with and without obstructive coronary artery disease: results from Women's Ischemia Syndrome Evaluation (WISE) (2020) (0)
Abstract 15742: Long Term Clinical Outcomes and Major Adverse Cardiac Event Rates of Enhanced External Counterpulsation Therapy in the Real World Settings in Patients with Coronary Artery Disease and Left Ventricular Dysfunction (2011) (0)
Subject Index Vol. 19, 2000 (2000) (0)
The Heart Failure Home Care (HFHC) Trial : A Multicenter, Randomized, Controlled Trial of a Computer Based Telephonic Heart Failure Monitoring System: Design and Methods (2003) (0)
Abstract 14469: Risk Factors for the Development of Heart Failure in Women Without Obstructive Coronary Artery Disease. A Follow Up Study From the National Heart, Lung, and Blood Institute-sponsored Women’s Ischemia Syndrome Evaluation (WISE) (2016) (0)
RELATION BETWEEN CORONARY FLOW RESERVE AND AORTIC WAVE REFLECTIONS: AN ANCILLARY STUDY FROM THE NHLBI-SPONSORED WOMEN'S ISCHEMIA SYNDROME EVALUATION (2013) (0)
Women Versus Men Regarding Outcome of CABG or PTCA Response (1999) (0)
Diabetes and the EVS: A Different Interpretation of the Results (2002) (0)
747 Does enhanced external counterpulsation treatment reduce emergengy room visits and hospitalizations in refractoy angina patients with left ventricular dysfunction (2005) (0)
Inflammation is not associated with coronary microvascular dysfunction in women with chest pain (2003) (0)

This paper list is powered by the following services:

Other Resources About Sheryl F. Kelsey

en.wikipedia.org

What Schools Are Affiliated With Sheryl F. Kelsey?

Sheryl F. Kelsey is affiliated with the following schools:

Sheryl F. Kelsey's Academic­Influence.com Rankings

Why Is Sheryl F. Kelsey Influential?

Sheryl F. Kelsey's Published Works

Published Works

Other Resources About Sheryl F. Kelsey

What Schools Are Affiliated With Sheryl F. Kelsey?

Sheryl F. Kelsey's AcademicInfluence.com Rankings